Nivolumab vs Rosuvastatin

## Nivolumab vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Rosuvastatin**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Rosuvastatin**: Competitive inhibitor of HMG-CoA reductase.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Rosuvastatin — 19 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Rosuvastatin — C22H28FN3O6S.

**Molecular Weight**: Nivolumab — N/A; Rosuvastatin — 481.5390 g/mol.

**Type**: Nivolumab — Antibody; Rosuvastatin — Small molecule.